American Oncology Network, Inc.
AONC · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $490,884 | $470,279 | $433,982 | $364,339 |
| % Growth | 4.4% | 8.4% | 19.1% | – |
| Cost of Goods Sold | $448,355 | $433,746 | $404,589 | $354,948 |
| Gross Profit | $42,529 | $36,533 | $29,393 | $9,391 |
| % Margin | 8.7% | 7.8% | 6.8% | 2.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $34,184 | $34,738 | $36,738 | $28,277 |
| SG&A Expenses | $34,184 | $34,738 | $36,738 | $28,277 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $128 | $194 | $664 | $352 |
| Operating Expenses | $34,312 | $34,932 | $37,402 | $28,629 |
| Operating Income | $8,217 | $1,601 | -$8,009 | -$19,238 |
| % Margin | 1.7% | 0.3% | -1.8% | -5.3% |
| Other Income/Exp. Net | -$5,884 | -$3,161 | $4,560 | -$2,878 |
| Pre-Tax Income | $2,333 | -$1,560 | -$3,449 | -$22,116 |
| Tax Expense | -$72 | -$283 | -$324 | $2,894 |
| Net Income | $1,316 | -$1,069 | $3,621 | -$7,841 |
| % Margin | 0.3% | -0.2% | 0.8% | -2.2% |
| EPS | -0.003 | -0.19 | 0.12 | -1.22 |
| % Growth | 98.7% | -258.3% | 109.8% | – |
| EPS Diluted | -0.003 | -0.19 | 0.038 | -1.22 |
| Weighted Avg Shares Out | 13,491 | 13,264 | 11,377 | 7,528 |
| Weighted Avg Shares Out Dil | 13,491 | 13,264 | 10,396 | 7,528 |
| Supplemental Information | – | – | – | – |
| Interest Income | $744 | $637 | $1,025 | $793 |
| Interest Expense | $1,587 | $1,874 | $1,833 | $1,763 |
| Depreciation & Amortization | $5,522 | $4,629 | $4,674 | $4,546 |
| EBITDA | $9,442 | $4,943 | $3,237 | -$15,807 |
| % Margin | 1.9% | 1.1% | 0.7% | -4.3% |